atrial fibrillation and stroke prevention - Continuing Medical ...
atrial fibrillation and stroke prevention - Continuing Medical ...
atrial fibrillation and stroke prevention - Continuing Medical ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Essentials in Primary Care Conference<br />
Wednesday, July 31, 2013<br />
Apixaban Dosing in A Fib<br />
• 5 mg twice daily<br />
• 2.5 mg twice daily for either:<br />
-Age > 80 yrs of age<br />
-Body weight 60 Kg or less<br />
-Creatinine > 1.5 mg/dl<br />
-Dual inhibitors of cytochrome P450 3A4 <strong>and</strong><br />
p-glycoprotein such as ketoconazole <strong>and</strong><br />
clarithromycin<br />
Warfarin Comparison Trials in Atrial Fib<br />
TRIAL RE-LY ROCKET-AF ARISTOTLE<br />
n =18,113 (3 arms) n=14,264 n=18,201<br />
Drug (Br<strong>and</strong> name) Dabigatran (Pradaxa) Rivaroxaban (Xarelto) Apixiban (Eliquis)<br />
150 mg twice a day 20 mg once daily with 5 mg twice a day<br />
evening meal<br />
Trial design, r<strong>and</strong>omized Open label Double blind, double dummy Double blind, double dummy<br />
Mean Age (yrs) 72 73 70<br />
Male ratio 63.6% 60.1% 65.3%<br />
Previous CVA 20% 55% 19%<br />
CHADS score mean 2.1 3.5 2.1<br />
% 0-1 32% 0% 34%<br />
% >3 33% 87% 30%<br />
TTR (%) median/mean ? / 64% 57.8% / 55% 66.0% / 62.2%<br />
Efficacy % vs warfarin 1.71 vs. 1.11 p